Zai Lab Ltd (NAS:ZLAB)
$ 17.92 -1.14 (-5.98%) Market Cap: 1.79 Bil Enterprise Value: 1.34 Bil PE Ratio: 0 PB Ratio: 2.43 GF Score: 67/100

Zai Lab Ltd at Citi BioTech C-Suite Fireside Chat Series (Virtual) Transcript

Feb 14, 2023 / 04:00PM GMT
Release Date Price: $37.99 (-5.94%)
Yigal Dov Nochomovitz
Citigroup Inc., Research Division - Director

I'm Yigal Nochomovitz. I'm one of the biotech analysts here at Citi. This is a continuation of our newly introduced C-suite series where we feature management from some of our covered companies for a 1-hour discussion about the pipeline and other topics.

So it's my great pleasure to have with me this morning, Josh Smiley, who is the COO of Zai Lab. Josh started in August of 2022 after a 26-year career at Lilly. (Operator Instructions) So Josh, welcome. Thank you so much for taking the time to speak with us for an hour. I appreciate it.

Questions & Answers

Yigal Dov Nochomovitz
Citigroup Inc., Research Division - Director

I think a lot of people are familiar with Zai Lab, but I think a lot of people also aren't. So I think maybe to start with, if you could just outline the strategic vision for the company over the next, say, 5 or 10 years. How do you see the mission evolving, both in the pipeline as well as the commercial side? And how do you see the transformation of Zai

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot